Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEALEY ALS Platform Trial - Regimen C
NCT04414345Phase 3Completed
- Start
- Jul 2020
- Primary completion
- Apr 2022
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of CNM-Au8 in amyotrophic lateral sclerosis (ALS). Started Jul 2020; status: completed.
02
Drugs
CNM-Au8
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT04414345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04414345.